Balancing Economics and Ethics: How Can VA/HTA Support Equitable Resource Allocation?

ISPOR and the Innovation and Value Initiative (IVI) are collaborating on a series of dialogues that highlight key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic.  Evolving data from COVID-19 tell the story we already know: the impact of this disease affects people – especially people of color – disproportionately, both in terms of risk and prevalence, as well as access to care and outcomes. In considering VA/HTA approaches, as well as in discerning how to apply such findings, how must we address questions of ethics and equity?

After attending this webinar, participants will be able to

  • Discuss key ethical issues in allocating limited resources in fighting against COVID-19 in the US and globally
  • Consider how to account for vulnerable populations especially at risk, and their needs
  • Evaluate the importance of equity in VA/HTA
  • Identify methods and their readiness to address equity in distribution of tests, treatments, and vaccines


Jennifer Bright, MPA
Executive Director
Innovation and Value Initiative (IVI)
Alexandria, VA, USA


Jennifer Miller, PhD
Assistant Professor
Yale University
New Haven, USA

Laurie Zephyrin, MD
Vice President, Delivery System Reform
The Commonwealth Fund
Washington DC, USA

Amber Hewitt, PhD
Director, Health Equity
Families USA
Washington DC, USA